128 related articles for article (PubMed ID: 6265359)
1. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.
Ruebush MJ; Hale AH; Harris DT
Infect Immun; 1981 May; 32(2):513-7. PubMed ID: 6265359
[TBL] [Abstract][Full Text] [Related]
2. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
Ciavarra R; Forman J
J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
Bowman MR; Lyles DS; Parce JW
J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
[TBL] [Abstract][Full Text] [Related]
4. Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes.
Loh D; Ross AH; Hale AH; Baltimore D; Eisen HN
J Exp Med; 1979 Nov; 150(5):1067-74. PubMed ID: 227980
[TBL] [Abstract][Full Text] [Related]
5. Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.
Hale AH; Witte ON; Baltimore D; Eisen HN
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):970-4. PubMed ID: 204941
[TBL] [Abstract][Full Text] [Related]
6. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
Hale AH; Lyles DS; Fan DP
J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
Hale AH; Ruebush MJ; Lefrançois L
Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
[TBL] [Abstract][Full Text] [Related]
9. The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells.
Sethi KK; Brandis H
Eur J Immunol; 1980 Apr; 10(4):268-72. PubMed ID: 6249612
[No Abstract] [Full Text] [Related]
10. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
Harris DT; Hale AH; Lefrancois L
J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
[TBL] [Abstract][Full Text] [Related]
11. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
Rosenthal KL; Zinkernagel RM
J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
[TBL] [Abstract][Full Text] [Related]
12. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
Roscoe DM; Ishikawa K; Lyles DS
J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
[TBL] [Abstract][Full Text] [Related]
13. Elicitation of primary anti-Sendai virus cytotoxic T lymphocytes with purified viral glycoproteins.
McGee M; Hale AH; Panetti M
Eur J Immunol; 1980 Dec; 10(12):923-8. PubMed ID: 6258925
[TBL] [Abstract][Full Text] [Related]
14. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
Ciavarra RP; Burgess DH
Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostaglandins on elicitation of anti-viral-cytolytic activity.
Hale AH; Evans DL; Daniel LW
Immunol Lett; 1982 Mar; 4(3):171-4. PubMed ID: 6281179
[TBL] [Abstract][Full Text] [Related]
16. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
Zinkernagel RM; Althage A; Holland J
J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
[TBL] [Abstract][Full Text] [Related]
17. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
Hale AH; Ruebush MJ; Harris DT
J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
[TBL] [Abstract][Full Text] [Related]
18. Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus.
Kündig TM; Castelmur I; Bachmann MF; Abraham D; Binder D; Hengartner H; Zinkernagel RM
J Virol; 1993 Jun; 67(6):3680-3. PubMed ID: 7684471
[TBL] [Abstract][Full Text] [Related]
19. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
Forman J; Goodenow RS; Hood L; Ciavarra R
J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
[TBL] [Abstract][Full Text] [Related]
20. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
